Heteromeric KCNE2/KCNQ1 potassium channels in the luminal membrane of gastric parietal cells
Recently, we and others have shown that luminal K + recycling via KCNQ1 K + channels is required for gastric H + secretion. Inhibition of KCNQ1 by the chromanol 293B strongly diminished H + secretion. The present study aims at clarifying KCNQ1 subunit composition, subcellular localization, regulatio...
Gespeichert in:
Veröffentlicht in: | The Journal of physiology 2004-12, Vol.561 (2), p.547-557 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Recently, we and others have shown that luminal K + recycling via KCNQ1 K + channels is required for gastric H + secretion. Inhibition of KCNQ1 by the chromanol 293B strongly diminished H + secretion. The present study aims at clarifying KCNQ1 subunit composition, subcellular localization, regulation and pharmacology
in parietal cells. Using in situ hybridization and immunofluorescence techniques, we identified KCNE2 as the β subunit of KCNQ1 in the luminal membrane compartment
of parietal cells. Expressed in COS cells, hKCNE2/hKCNQ1 channels were activated by acidic pH, PIP 2 , cAMP and purinergic receptor stimulation. Qualitatively similar results were obtained in mouse parietal cells. Confocal
microscopy revealed stimulation-induced translocation of H + ,K + -ATPase from tubulovesicles towards the luminal pole of parietal cells, whereas distribution of KCNQ1 K + channels did not change to the same extent. In COS cells the 293B-related substance IKs124 blocked hKCNE2/hKCNQ1 with an
IC 50 of 8 n m . Inhibition of hKCNE1- and hKCNE3-containing channels was weaker with IC 50 values of 370 and 440 n m , respectively. In conclusion, KCNQ1 coassembles with KCNE2 to form acid-activated luminal K + channels of parietal cells. KCNQ1/KCNE2 is activated during acid secretion via several pathways but probably not by targeting
of the channel to the membrane. IKs124 could serve as a leading compound in the development of subunit-specific KCNE2/KCNQ1
blockers to treat peptic ulcers. |
---|---|
ISSN: | 0022-3751 1469-7793 |
DOI: | 10.1113/jphysiol.2004.075168 |